- What the Public Data Actually Shows
- Why There Is No Verified Pass Rate to Quote
- Reading the Blueprint as a Pass-Rate Proxy
- The Heavy Domains: Where Most Points Live
- The Lighter Domains: Small Weights, Real Risk
- Who Sits This Exam and Why It Matters
- A Domain-Weighted Study Sequence
- Fees, Question Count, and Testing Provider: What Is Unverified
- Frequently Asked Questions
- The public sources reviewed did not verify a pass rate for the Biochemical Genetics examination, so any quoted figure should be treated with suspicion.
- The ABMGG 2025 Biochemical Genetics Blueprint lists 15 content domains with approximate percentages that sum to 100%.
- Amino acids (15%), lipids (13%), organic acids (12%), and lysosomes (12%) together account for 52% of the blueprint.
- Small domains like creatine (1%) and neurotransmitters (2%) are low-weight, but weak coverage of many small areas adds up.
What the Public Data Actually Shows
If you searched for the Medical Biochemical Genetics pass rate, you probably wanted a clean percentage. Here is the honest answer: the sources reviewed for this article, centered on the ABMGG 2025 Biochemical Genetics Blueprint and Content Codes, did not verify a public pass rate for this specialty examination. They also did not verify a public question count, a fee, or a testing provider.
That may feel unsatisfying, but it is more useful than a made-up statistic. Medical Biochemical Genetics is a small, specialized discipline governed by the American Board of Medical Genetics and Genomics (ABMGG). The population of people who sit for it each cycle is small, and small populations make published pass-rate figures both rare and volatile. Any number you find on a forum or a third-party site without a named source should be treated as unverified.
What is public and official is the content blueprint. That is the real, usable data, and this article shows you how to read it as a practical stand-in for "how hard is this and where will I lose points." For a broader view of exam difficulty, see our complete difficulty guide for the MBG exam.
Why There Is No Verified Pass Rate to Quote
Several structural reasons explain why a trustworthy pass rate is hard to pin down for this credential.
A small and specialized candidate pool
Biochemical genetics is a narrow subspecialty. Candidates typically come out of clinical training pathways tied to genetics and genomics, and the number testing in any given window is modest. When cohorts are small, a single year's results swing widely and tell you little about your own odds.
Certifying bodies do not always publish outcomes
Boards are not obligated to publish pass-rate tables for every examination. The public sources reviewed for this article described the content blueprint but did not report outcome statistics. Absent an official release, any figure circulating online is secondhand at best.
Pass rate is a weak predictor of your result anyway
Even if a verified rate existed, it would blend very different candidates: those with deep laboratory backgrounds, those coming from a primarily clinical track, repeat testers, and first-timers. Your outcome depends on your preparation against the content, which is why the blueprint is the better planning tool. If you want the scoring side of the question, our guide to the MBG passing score covers what is and is not publicly documented.
Reading the Blueprint as a Pass-Rate Proxy
When no pass rate is available, the next best thing is to understand where the exam concentrates its points. The 2025 blueprint gives approximate percentages for each of 15 domains. Here they are in full:
| Domain | Approximate Weight |
|---|---|
| Amino acids | 15% |
| Lipids | 13% |
| Organic acids | 12% |
| Lysosomes | 12% |
| Carbohydrates | 10% |
| Laboratory | 8% |
| Cofactors | 7% |
| Mitochondria | 7% |
| Peroxisomes | 3% |
| Purines and pyrimidines | 3% |
| Transport | 3% |
| Metals | 3% |
| Other disease category | 3% |
| Neurotransmitters | 2% |
| Creatine | 1% |
These are described as official exam content topics with approximate percentages, so treat them as guidance on emphasis rather than a guaranteed item count per domain. For a domain-by-domain walkthrough, our complete guide to all 15 MBG content areas goes deeper on each one.
The Heavy Domains: Where Most Points Live
If you cannot predict a pass rate, you can at least predict where your preparation time pays off most. These are the domains that deserve the largest share of your hours.
Amino Acids (15%)
The single largest domain. Candidates must connect enzyme defects to pathway position, characteristic metabolite patterns, and clinical presentation.
- Know the pathway logic well enough to predict which metabolites accumulate upstream of a block
- Be fluent in how amino acid disorders appear on plasma amino acid analysis versus urine organic acid profiles
- Understand the rationale behind dietary and pharmacologic management strategies
Lipids (13%)
The second-largest domain spans fatty acid metabolism and broader lipid disorders.
- Link fatty acid oxidation defects to the acylcarnitine and organic acid patterns they produce
- Understand how fasting stress unmasks these disorders clinically
- Be able to distinguish related defects that look similar on first-pass screening
Organic Acids (12%)
Organic acid disorders reward pattern recognition more than rote recall.
- Practice reading urine organic acid profiles and naming the likely block
- Know which disorders present with acute decompensation and which are more insidious
- Understand the overlap with amino acid and cofactor domains, since many conditions straddle categories
Lysosomes (12%)
Lysosomal storage disease is a large, name-heavy domain where organization is everything.
- Group disorders by the type of accumulating substrate rather than memorizing an alphabetical list
- Connect each disorder to its deficient enzyme or transport protein and the typical clinical phenotype
- Know the role of enzyme assays and how results are interpreted
Because these four domains overlap conceptually with carbohydrates (10%) and cofactors (7%), solid command of core metabolic pathways pays off across the entire exam rather than in a single category. Our MBG study guide lays out how to build that pathway foundation first.
The Lighter Domains: Small Weights, Real Risk
It is tempting to skip anything under 5%. That is a mistake worth examining, because the blueprint contains many small domains, and together they are not trivial.
Peroxisomes (3%), purines and pyrimidines (3%), transport (3%), metals (3%), and the "other disease category" (3%) add up to 15%. Include neurotransmitters (2%) and creatine (1%) and the small domains together reach 18%. That is more than the amino acids domain alone.
The good news is that these areas are bounded. A creatine disorder question draws from a short list of conditions; you can learn that list quickly. The risk is not that these topics are hard but that they are easy to neglect.
Where to be strategic
- Metals (3%): Learn the major copper and other metal-handling disorders and their characteristic laboratory and clinical findings.
- Peroxisomes (3%): Focus on the biochemical markers used to recognize peroxisomal disorders and how they relate to clinical presentations.
- Purines and pyrimidines (3%): Know the key enzyme defects and the distinctive metabolites they generate.
- Neurotransmitters (2%) and creatine (1%): Brief, high-yield review sessions are enough; do not let them consume weeks.
Key Takeaway
Treat the small domains as cheap points. A short, focused review of each late in your preparation costs far less time than the heavy domains and protects you from losing easy marks.
Who Sits This Exam and Why It Matters
The Biochemical Genetics examination is administered under ABMGG, and eligibility is tied to the board's training and credentialing pathways. Because those pathways are specialized, the candidate pool skews toward people who already have substantial exposure to inborn errors of metabolism in clinical or laboratory settings.
That has two implications for how you interpret any "pass rate" talk:
- Selection effects. Candidates are typically well-prepared by training before they ever open a review resource, which can make aggregate outcomes look favorable without telling you what a first-time candidate with gaps should expect.
- The Laboratory domain (8%). Candidates from clinical tracks sometimes underweight laboratory interpretation, while those from laboratory tracks may be less comfortable with clinical management. The blueprint tests both, so know which side you are weaker on.
For specifics on who qualifies to test, review our breakdown of MBG requirements and eligibility, and confirm current rules directly with ABMGG since eligibility details can change.
A Domain-Weighted Study Sequence
Rather than a generic schedule, here is a sequence that follows the blueprint. Adjust the length to your own timeline; the ordering logic is what matters: build the pathway foundation, then work the heavy domains, then sweep the small ones, then practice interpretation.
Foundations and Amino Acids (15%)
- Review core metabolic pathways that underlie almost every domain
- Work through amino acid disorders by pathway position
- Pair each disorder with its expected laboratory pattern
Organic Acids (12%) and Lipids (13%)
- Practice reading organic acid and acylcarnitine patterns
- Study fatty acid oxidation and related lipid disorders together, since presentations overlap
Lysosomes (12%) and Carbohydrates (10%)
- Organize storage disorders by accumulating substrate
- Cover glycogen storage, galactose, and fructose metabolism disorders
Cofactors (7%) and Mitochondria (7%)
- Link cofactor disorders back to the enzymes that depend on them
- Review mitochondrial disease biochemistry and its overlap with organic acid findings
Laboratory (8%) and the Small Domains
- Drill assay interpretation and pitfalls
- Sweep peroxisomes, purines and pyrimidines, transport, metals, neurotransmitters, creatine, and the other disease category
For a one-page memory aid to use during these phases, see the MBG cheat sheet. When you are ready to test retention, work through realistic questions in the MBG practice test.
Fees, Question Count, and Testing Provider: What Is Unverified
Candidates naturally want logistics alongside the pass rate. Here is exactly where the public record stands based on the sources reviewed:
| Item | Status in Sources Reviewed |
|---|---|
| Governing body | American Board of Medical Genetics and Genomics (ABMGG) |
| Content domains | 15 domains with approximate percentages (2025 blueprint) |
| Public pass rate | Not verified |
| Public question count | Not verified |
| Public fee | Not verified |
| Testing provider | Not verified |
Because fee and scheduling details were not verified, do not budget from third-party numbers. Contact ABMGG directly for current fee schedules and application windows. Our pages on MBG certification cost and MBG exam dates explain how to approach those questions without relying on unverified figures.
What this means for your decision
Uncertainty about outcome statistics should not stall your preparation. The blueprint is public, the domains are defined, and the weights tell you where to invest. If you are weighing whether the credential fits your career, our analysis of whether the MBG certification is worth it and the MBG salary guide discuss that decision qualitatively, without inventing numbers the sources do not support.
Frequently Asked Questions
No pass rate was verified in the public sources reviewed, which centered on the ABMGG 2025 Biochemical Genetics Blueprint and Content Codes. Treat any unsourced figure you encounter with caution, and contact ABMGG if you need official outcome information.
According to the 2025 blueprint, amino acids lead at approximately 15%, followed by lipids (13%), organic acids (12%), and lysosomes (12%). Carbohydrates (10%) and laboratory (8%) come next.
It is risky to skip them. Peroxisomes, purines and pyrimidines, transport, metals, and the other disease category are each about 3%, with neurotransmitters at 2% and creatine at 1%. Together the small domains are a meaningful share of the blueprint, and they are relatively quick to review.
Not in the sources reviewed. The public question count, fee, and testing provider were not verified, so confirm those details directly with ABMGG before scheduling or budgeting.
Begin with the MBG study guide for structure, review each content area in the domains guide, and then test yourself with questions on the main practice site.
In the absence of a verified pass rate, the strongest move is to prepare against what is documented: 15 domains, clear weights, and a heavy concentration of points in amino acids, lipids, organic acids, and lysosomes. Build your plan from the blueprint, confirm logistics with ABMGG, and let your own practice results, not a rumor, tell you when you are ready.